According to Zen Score, the 3 best healthcare plan stocks to buy right now are:
1. Molina Healthcare (NYSE:MOH)
Molina Healthcare (NYSE:MOH) is the top healthcare plan stock with a Zen Score of 60, which is 24 points higher than the healthcare plan industry average of 36. It passed 19 out of 33 due diligence checks and has strong fundamentals. Molina Healthcare has seen its stock lose -20.68% over the past year, underperforming other healthcare plan stocks by -15 percentage points.
Molina Healthcare has an average 1 year
price target of $357.82, an upside of 33.65% from Molina Healthcare's current stock price of $267.72.
Molina Healthcare stock has a consensus Buy recommendation according to Wall Street analysts. Of the 11 analysts covering Molina Healthcare, 36.36% have issued a Strong Buy rating, 18.18% have issued a Buy, 36.36% have issued a hold, while 0% have issued a Sell rating, and 9.09% have issued a Strong Sell.
2. Cigna Group (NYSE:CI)
Cigna Group (NYSE:CI) is the second best healthcare plan stock with a Zen Score of 53, which is 17 points higher than the healthcare plan industry average of 36. It passed 19 out of 38 due diligence checks and has strong fundamentals. Cigna Group has seen its stock return 7.48% over the past year, overperforming other healthcare plan stocks by 13 percentage points.
Cigna Group has an average 1 year
price target of $325.48, an upside of 25.08% from Cigna Group's current stock price of $260.21.
Cigna Group stock has a consensus Buy recommendation according to Wall Street analysts. Of the 21 analysts covering Cigna Group, 42.86% have issued a Strong Buy rating, 19.05% have issued a Buy, 38.1% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.
3. Elevance Health (NYSE:ELV)
Elevance Health (NYSE:ELV) is the third best healthcare plan stock with a Zen Score of 47, which is 11 points higher than the healthcare plan industry average of 36. It passed 17 out of 38 due diligence checks and has strong fundamentals. Elevance Health has seen its stock lose -3.6% over the past year, overperforming other healthcare plan stocks by 2 percentage points.
Elevance Health has an average 1 year
price target of $531.64, an upside of 16.41% from Elevance Health's current stock price of $456.69.
Elevance Health stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 14 analysts covering Elevance Health, 50% have issued a Strong Buy rating, 28.57% have issued a Buy, 21.43% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.